Indian J Med Microbiol Close
 

Figure 5: B-cell epitope studies with different methods were performed for all the vaccine candidate proteins, and the results for 50S ribosomal protein L2 are shown above. (A) BepiPred linear epitope prediction. (B) Chou and Fasman beta-turn prediction. (C) Emini surface accessibility prediction. (D) Karplus and Schulz flexibility prediction. (E) Kolaskar and Tongaonkar antigenicity prediction. (F) Parker hydrophobicity prediction

Figure 5: B-cell epitope studies with different methods were performed for all the vaccine candidate proteins, and the results for 50S ribosomal protein L2 are shown above. (A) BepiPred linear epitope prediction. (B) Chou and Fasman beta-turn prediction. (C) Emini surface accessibility prediction. (D) Karplus and Schulz flexibility prediction. (E) Kolaskar and Tongaonkar antigenicity prediction. (F) Parker hydrophobicity prediction